Rob Pitt recently joined Mtech Access as a Developer working on our iPad applications, web-based tools and Veeva-integrated interactive presentations. These digital tools and presentation aids are used by our...
Read More
In this webinar, we explored the challenges facing orphan medicines and other innovative rare disease treatments looking to achieve market access in Europe. Orphan medicines and rare disease treatments are...
Read More
On World Evidence-Based Healthcare Day (20th October 2021), Shona Lang (Senior Consultant -Evidence Synthesis), Stephanie Swift (Consultant - Evidence Synthesis) and Calum Jones (Consultant Health Economist) explore the role of...
Read More
How will medicines be valued in the newly integrated world of the NHS? What are the risks and benefits of a single national formulary? What else is changing? And what...
Read More
Katriona Withers recently joined Mtech Access as a Senior Analyst working on global market access projects. In this interview, she tells us about her experiences and activities in her first...
Read More
Will Amesbury recently joined Mtech Access as a Graphic Designer working on our digital tools and customer communication materials. In this interview, he tells us about his experiences and activities...
Read More
To celebrate World Patient Safety Day 2021, Dr Stephanie Swift and Dr Shona Lang, Consultant and Senior Consultant in Systematic Reviews and Evidence Synthesis at Mtech Access, highlight some of...
Read More
Following over 25 years in the pharmaceutical industry engaging directly with NHS decision-makers, and having spent several years working for the NHS as Head of Engagement, Karen Cooper recently joined...
Read More
How are healthcare systems looking differently at their population to deliver better care and what does this mean for future decision-making? How might the NHS re-imagine the hospital? What benefits...
Read More
Finding, bringing together and synthesising a comprehensive evidence base is a key part of the reimbursement process and the wider market access journey for pharmaceutical products. This evidence generation process...
Read More
